252 related articles for article (PubMed ID: 20547195)
1. Biomonitoring equivalents for inorganic arsenic.
Hays SM; Aylward LL; Gagné M; Nong A; Krishnan K
Regul Toxicol Pharmacol; 2010 Oct; 58(1):1-9. PubMed ID: 20547195
[TBL] [Abstract][Full Text] [Related]
2. Biomonitoring Equivalents for triclosan.
Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):10-7. PubMed ID: 20541577
[TBL] [Abstract][Full Text] [Related]
3. Biomonitoring Equivalents for bisphenol A (BPA).
Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
[TBL] [Abstract][Full Text] [Related]
4. Biomonitoring equivalents for hexachlorobenzene.
Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
[TBL] [Abstract][Full Text] [Related]
5. Biomonitoring Equivalents for benzene.
Hays SM; Pyatt DW; Kirman CR; Aylward LL
Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
[TBL] [Abstract][Full Text] [Related]
6. Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7).
Aylward LL; Hays SM; Gagné M; Krishnan K
Regul Toxicol Pharmacol; 2009 Dec; 55(3):249-58. PubMed ID: 19751789
[TBL] [Abstract][Full Text] [Related]
7. Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP).
Aylward LL; Hays SM; Gagné M; Krishnan K
Regul Toxicol Pharmacol; 2009 Dec; 55(3):259-67. PubMed ID: 19751787
[TBL] [Abstract][Full Text] [Related]
8. Derivation of Biomonitoring Equivalents for cyfluthrin.
Hays SM; Aylward LL; Gagné M; Krishnan K
Regul Toxicol Pharmacol; 2009 Dec; 55(3):268-75. PubMed ID: 19751788
[TBL] [Abstract][Full Text] [Related]
9. Biomonitoring equivalents for DDT/DDE.
Kirman CR; Aylward LL; Hays SM; Krishnan K; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):172-80. PubMed ID: 21466830
[TBL] [Abstract][Full Text] [Related]
10. Biomonitoring equivalents for di-isononyl phthalate (DINP).
Hays SM; Aylward LL; Kirman CR; Krishnan K; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):181-8. PubMed ID: 21466828
[TBL] [Abstract][Full Text] [Related]
11. Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9).
Hays SM; Nordberg M; Yager JW; Aylward LL
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S49-56. PubMed ID: 18579269
[TBL] [Abstract][Full Text] [Related]
12. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).
Aylward LL; Barton HA; Hays SM
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S27-36. PubMed ID: 18583006
[TBL] [Abstract][Full Text] [Related]
13. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
Aylward LL; Kirman CR; Blount BC; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
[TBL] [Abstract][Full Text] [Related]
14. Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context.
St-Amand A; Werry K; Aylward LL; Hays SM; Nong A
Toxicol Lett; 2014 Dec; 231(2):126-34. PubMed ID: 25455445
[TBL] [Abstract][Full Text] [Related]
15. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).
Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S37-48. PubMed ID: 18579270
[TBL] [Abstract][Full Text] [Related]
16. Biomonitoring equivalents for deltamethrin.
Aylward LL; Krishnan K; Kirman CR; Nong A; Hays SM
Regul Toxicol Pharmacol; 2011 Jul; 60(2):189-99. PubMed ID: 21466827
[TBL] [Abstract][Full Text] [Related]
17. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
Hays SM; Aylward LL
Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
[TBL] [Abstract][Full Text] [Related]
18. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
[TBL] [Abstract][Full Text] [Related]
19. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.
Hays SM; Aylward LL
J Appl Toxicol; 2009 May; 29(4):275-88. PubMed ID: 19115313
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.
Hays SM; Aylward LL; LaKind JS; Bartels MJ; Barton HA; Boogaard PJ; Brunk C; DiZio S; Dourson M; Goldstein DA; Lipscomb J; Kilpatrick ME; Krewski D; Krishnan K; Nordberg M; Okino M; Tan YM; Viau C; Yager JW;
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S4-15. PubMed ID: 18583008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
